ProCE Banner Activity

Beware of the Troll: Preventing CMV After Solid Organ Transplantation

Clinical Thought

Here’s what I consider when selecting between universal prophylaxis and preemptive therapy to prevent CMV disease in high-risk solid transplant recipients.

 

Released: August 30, 2023

Share

Faculty

Hannah Imlay

Hannah Imlay, MD, MS

Assistant Professor 
Internal Medicine/Infectious Diseases 
University of Utah 
Salt Lake City, Utah 

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme Corp.

Merck Sharp & Dohme Corp.

Disclosure

Primary Author

Hannah Imlay, MD, MS

Assistant Professor 
Internal Medicine/Infectious Diseases 
University of Utah 
Salt Lake City, Utah 

Hannah Imlay, MD, MS: consultant/advisor/speaker: Medscape, UpToDate.